News
Nordic Society for Clinical Chemistry, June 12-15, Reykjavik, Iceland
May 22 2012
ERA-EDTA, May 24-27, Paris, France
May 08 2012
BioPorto Diagnostics Product overview 2012
March 02 2012
ISICEM 2012, March 20-23, Brussels, Belgium
February 23 2012
CRITICARE, February 15-19, Pune, India
January 24 2012
Conference on Continuous Renal Replacement Therapies (CRRT), February 12-15, San Diego, USA
January 24 2012
MEDLAB, Arab Health, January 23-26, Dubai, UAE
January 16 2012
An addition to the Obesity and Type 2 Diabetes antibody portfolio
December 22 2011
Better kidney markers ahead?
December 05 2011
New NGAL.com website launched
November 24 2011
An addition to the Obesity and Type 2 Diabetes antibody portfolio
December 22 2011 by BioPorto Diagnostics
BioPorto Diagnostics is pleased to announce the launch of new monoclonal antibodies
The launch of two new Anti-Glucagon (human, pig, rat) antibodies provides a tool for measuring free glucagon levels. The two antibodies are designed to work together as a sandwich antibody pair.
BioPorto Diagnostics offers an extensive range of monoclonal antibodies within the Obesity and Type 2 Diabetes area. These antibodies are widely used by researchers and pharmaceutical companies around the world. Especially in the field of obesity and type-2 diabetes, these antibodies give researchers a unique opportunity to measure relevant peptide hormones.
